Trademark: 97205484
Word
ATTENUKINE
Status
Pending
Status Code
730
Status Date
Wednesday, January 10, 2024
Serial Number
97205484
Mark Type
4000
Filing Date
Thursday, January 6, 2022
Published for Opposition
Tuesday, May 23, 2023

Trademark Owner History
Teva Pharmaceutical Industries Ltd. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cancer and autoimmune diseases

Trademark Events
Jan 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2024
Sou Extension 1 Granted
Jan 10, 2024
Sou Extension 1 Filed
Jan 10, 2024
Sou Teas Extension Received
Jul 18, 2023
Noa E-Mailed - Sou Required From Applicant
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 17, 2023
Approved For Pub - Principal Register
Mar 16, 2023
Teas/Email Correspondence Entered
Mar 15, 2023
Correspondence Received In Law Office
Mar 15, 2023
Teas Response To Office Action Received
Oct 13, 2022
Notification Of Non-Final Action E-Mailed
Oct 13, 2022
Non-Final Action E-Mailed
Oct 13, 2022
Non-Final Action Written
Oct 13, 2022
Assigned To Examiner
Jan 10, 2022
New Application Office Supplied Data Entered
Jan 10, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24